Pfizer's current dividend yield stands at 6.7%, a figure that might alarm some investors. However, the overall dividend narrative suggests a more favorable outlook.
Despite the high yield, analysts indicate that Pfizer's dividend sustainability is stronger than it might seem at first glance.
Investors should consider the broader context of Pfizer's financial health and dividend strategy before making decisions based solely on yield.